AstraZeneca Aktie
WKN: 886455 / ISIN: GB0009895292
06.02.2025 23:00:31
|
Why AstraZeneca Topped the Market on Thursday
A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday. Investors were clearly impressed by the pharmaceutical company's numbers, as the stock closed the day more than 2% higher in value. This was notably better than the 0.4% bump of the S&P 500 index.AstraZeneca unveiled both its fourth-quarter and full-year 2024 results before market open today, revealing that its total revenue was $14.89 billion. This represented a meaty 24% improvement over Q4 2023's figure. On the bottom line the company's "core" (i.e., non-GAAP) earnings per share rose even more sharply, advancing by 44% to $2.09. There was quite some distance between AstraZeneca's performance and analyst estimates for the quarter. On average, pundits following the company were anticipating it would post a lower revenue number ($14.15 billion) and a far lower adjusted net profit of $1.06 per share. Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AstraZeneca PLCmehr Nachrichten
31.07.25 |
FTSE 100-Handel aktuell: FTSE 100 zum Ende des Donnerstagshandels in Rot (finanzen.at) | |
31.07.25 |
LSE-Handel: FTSE 100 verbucht am Nachmittag Gewinne (finanzen.at) | |
31.07.25 |
Donnerstagshandel in London: FTSE 100-Börsianer greifen zu (finanzen.at) | |
31.07.25 |
Gute Stimmung in London: FTSE 100 startet mit Gewinnen (finanzen.at) | |
30.07.25 |
Gewinne in Europa: STOXX 50 schlussendlich auf grünem Terrain (finanzen.at) | |
30.07.25 |
Freundlicher Handel: FTSE 100 zum Ende des Mittwochshandels in Grün (finanzen.at) | |
30.07.25 |
Schwacher Wochentag in London: FTSE 100 schwächelt am Mittwochnachmittag (finanzen.at) | |
30.07.25 |
STOXX-Handel: STOXX 50 nachmittags in der Gewinnzone (finanzen.at) |
Analysen zu AstraZeneca PLCmehr Analysen
30.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
29.07.25 | AstraZeneca Outperform | Bernstein Research | |
29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
29.07.25 | AstraZeneca Buy | UBS AG | |
29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |
Aktien in diesem Artikel
AstraZeneca PLC ADR Cert. Deposito Arg. Repr. 2 ADRs | 50 600,00 | 5,53% |
|
AstraZeneca PLC | 127,80 | -3,87% |
|
AstraZeneca PLC (spons. ADRs) | 66,00 | 8,20% |
|